布地奈德缓释胶囊(Kinpeygo)的正确购买途径

Introduction: Budesonide sustained-release capsule is an oral, sustained-release preparation of budesonide. Budesonide is a corticosteroid with strong glucocorticoid activity and weak mineralocorticoid activity, and undergoes a large amount of first-pass metabolism. Budesonide extended-release capsules are 4 mg extended-release capsules that are enteric-coated to remain intact until reaching the ileum.

Each budesonide extended-release capsule contains coated budesonide that targets mucosal B cells in the ileum, including Peyer's patches, which are responsible for the production of galactose-deficient IgA1 antibodies that cause IgA nephropathy.

The correct way to purchase generic medicines of budesonide extended-release capsules

Purchasing generic medicines should follow legal and safe guidelines. The following are some reference purchase channels.

1. Hospital pharmacy: In countries where generic budesonide sustained-release capsules are on the market, such as India, patients can visit local hospitals and purchase the drug directly in the hospital pharmacy.

2. Physical pharmacies: Physical pharmacies in countries or regions where generic budesonide sustained-release capsules are listed may sell the drug. Patients can go to local pharmacies for consultation and purchase.

3. Online pharmacies: Some online pharmacies may or may sell generic budesonide sustained-release capsules. Patients can place orders through online pharmacies and ensure that these pharmacies have legal drug sales licenses and can provide authenticity and quality assurance of drugs.

4. Medical service institutions: There are some domestic medical service institutions that may help purchase generic drugs. Patients can consult them to help purchase generic budesonide sustained-release capsules.

During the purchase process, be sure to pay attention to the source and quality of medicines and avoid buying fake and shoddy products to avoid harm to health. At the same time, understand before taking medication, use medication for special groups, etc.

Precautions for use of budesonide extended-release capsules

Patients with infection, hypertension, diabetes, osteoporosis, peptic ulcers, glaucoma or cataracts or a family history of diabetes or glaucoma, or any other condition for which use of glucocorticoids may be associated with an increased risk of adverse effects, should be monitored while taking budesonide extended-release capsules.

Usage of Budesonide Sustained-Release Capsules in Special Populations

1. Children: The safety and effectiveness of Budesonide Sustained-Release Capsules in pediatric patients have not yet been confirmed.

2. Elderly people: In the clinical study design of budesonide sustained-release capsules, a limited number of subjects aged 65 and above were included, so it is impossible to directly compare the differences in drug response between patients in this age group and younger subjects. Caution should be exercised in dose selection in elderly patients due to possible reduced hepatic, renal, or cardiac function and a higher rate of concomitant disease or polypharmacy.

3. Patients with liver damage: Because the systemic exposure of budesonide in the body may increase, patients with moderate to severe liver damage face a higher risk of hypercortical hyperfunction and adrenal axis suppression. The use of budesonide in patients with severe liver damage should be avoided. Patients with moderate liver damage should be closely monitored for signs or symptoms of hypercortical hyperfunction.